The efficacy and safety of anti-CD20 antibody for the treatment of B-ALL: a systematic review and meta-analysis.

Ther Adv Hematol · 2025 · PMC12717365 · PMID 41426224

Europe PMC DOI

hedged sentence

0.2500

closest p · 5.0× alpha

0.2500

boldest claim

The sentences

did not reach statistical significancep = 0.25not close (p > 0.1)

When subgroups were analyzed by study type, although a higher CR rate was also observed in the mab group in the RCTs, it did not reach statistical significance (OR = 1.39, 95%CI (0.79, 2.43), p = 0.25).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.